Discusses the firm's current portfolio outlook, investment strategies, and approach to valuation. Highlighted are preferred sectors and those to avoid; and favored companies and recent sells. Published date 6/16/03. Tickers featured: AIG, APA, APC, CSCO, CVX, DOW, EMC, EMN, EMR, GE, IP,...
Advanced molecular profiling of MM has revealed novel therapeutic targets that may aid in drug development. Nevertheless, MM is still incurable for the majority of patients, and new therapeutic approaches are required to improve patient survival. One of the hallmarks of MM is the excessive ...